Photo of: Carol Feghali-Bostwick

Prof. Carol Feghali-Bostwick

View Title...

Carol's profile was created using:
Sort By:

1-10 of 35 online sources for Carol Feghali-Bostwick

  • View Online Source
    www.citizensmemorial.com/body.cfm?xyzpdqabc=0&id=6&acti - [Cached Version]
    Published on: 12/13/2007    Last Visited: 12/13/2007  

    "We know it's not likely to be a single cause, which makes research more challenging," said Carol Feghali-Bostwick, an assistant professor of medicine in the division of pulmonary, allergy and critical medicine at the University of Pittsburgh's Simmons Center for Interstitial Lung Disease.

  • View Online Source
    www.healthday.com/Article.asp?AID=608355 - [Cached Version]
    Published on: 9/19/2007    Last Visited: 9/26/2007  

    "We don't want people to think we have found the final solution and answer," said Carol Feghali-Bostwick, an assistant professor of medicine and pathology at the University of Pittsburgh, and a member of the Scleroderma Foundation board of directors."But they have shown that having this particular sequence in your DNA puts you at risk.It is a good candidate gene, but it doesn't explain why some people have the sequence but not the disease."

    The researchers have found that the CTGF gene variant has lost the ability to regulate the production of the CTGF protein.

    "They took an extra step in understanding the variant gene's functional role," Feghali-Bostwick said.
    ...
    SOURCES: Gisela E. Lindhal, Ph.D., principal research fellow, University College Medical School, London; Carol Feghali-Bostwick, Ph.D., assistant professor, medicine and pathology, University of Pittsburgh; Sept. 20, 2007, New England Journal of Medicine

  • View Online Source
    www.forwoman.org/news/english/608355.htm - [Cached Version]
    Published on: 9/19/2007    Last Visited: 9/25/2007  

    "We don't want people to think we have found the final solution and answer," said Carol Feghali-Bostwick, an assistant professor of medicine and pathology at the University of Pittsburgh, and a member of the Scleroderma Foundation board of directors."But they have shown that having this particular sequence in your DNA puts you at risk.It is a good candidate gene, but it doesn't explain why some people have the sequence but not the disease."

    The researchers have found that the CTGF gene variant has lost the ability to regulate the production of the CTGF protein.

    "They took an extra step in understanding the variant gene's functional role," Feghali-Bostwick said.
    ...
    SOURCES: Gisela E. Lindhal, Ph.D., principal research fellow, University College Medical School, London; Carol Feghali-Bostwick, Ph.D., assistant professor, medicine and pathology, University of Pittsburgh; Sept. 20, 2007, New England Journal of Medicine

  • View Online Source
    www.fortherecordmag.com/archives/ftr_081808p24.shtml - [Cached Version]
    Published on: 8/18/2008    Last Visited: 10/5/2008  

    If this thickening affects the lungs, they can no longer function," explains Carol Feghali-Bostwick, PhD, an assistant professor of medicine in the division of pulmonary, allergy, and critical care medicine at the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh and vice chair of the board of directors of the Scleroderma Foundation.

    There are two types of scleroderma: systemic and localized.Systemic scleroderma is more serious and includes diagnoses of diffuse and limited cutaneous forms.It is more common in adults, presenting between the ages of 20 and 50, and approximately four times more common in women."For women, this is right in their childbearing years, and there is a theory that hormones may play a role in the susceptibility to scleroderma.But this is an area where further research is necessary," says Feghali-Bostwick.

    Localized scleroderma tends to be less severe.Its forms, including morphea and linear diagnoses, are more common in children and rarely progress to the systemic stage in adulthood, says Feghali-Bostwick.
    ...
    In patients with diffuse systemic disease, the progression can be very quick, but in those patients where the disease is caught early enough, it can be managed accordingly and, with an effective symptom management plan, some patients can enjoy a typical life expectancy, explains Feghali-Bostwick.

    Diagnosing systemic scleroderma is difficult because of the overlap in symptoms found in more common ailments, including gastrointestinal (GI) reflux disease, GI discomforts such as diarrhea and/or constipation, arthritis, carpal tunnel syndrome, stiffness and pain in joints and tendons, shortness of breath, kidney problems, pulmonary fibrosis, pulmonary hypertension, and Sjögren's syndrome (a chronic disease in which white blood cells attack moisture-producing glands in the body).

    However, one of the most common and somewhat telling signs of systemic scleroderma is Raynaud's phenomenon, a condition in which the fingers or toes change color due to the narrowing of blood vessels in the hands and feet."The hand color can be biphasic or triphasic, and the hands become very cold.Other parts of the body that are exposed to the cold can experience Raynaud's phenomenon such as the feet and nose," says Feghali-Bostwick.

    The first and most important step to determine if a patient has scleroderma is by performing a thorough physical, including a skin examination to determine its elasticity."In using a skin scoring system, the physician pinches various parts of the patient's body to test for thickness.The less skin that can be pinched equals a higher score in diagnosing scleroderma," says Feghali-Bostwick.

    In addition to the physical exam, certain tests can be ordered to determine how much the internal organs have been affected and if the patient has any of the antibodies associated with scleroderma."Currently, there are nine antibodies common to scleroderma that we can test for," says Feghali-Bostwick.
    ...
    However, we only have, at best, a 10- to 15-year history on these patients," says Feghali-Bostwick.Most deaths following a transplant are due to transplant complications.Meanwhile, to date, patients who survive do not seem to have any symptoms return to the transplanted lung, she adds.

    Scleroderma is not a cancer, nor is it contagious."It is likely a multigenic disease with environmental components serving as triggers," explains Feghali-Bostwick.Some studies have suggested there is an increased risk of developing the disease if a first-degree relative has been afflicted.However, other research disputes that theory."Studies looking at identical twins have found that it is not common for both twins who inherit the same genetic background to develop scleroderma," she says.

    One environmental factor that appears to influence the development of the disease and trigger its development in genetically susceptible patients is trichlorethylene, a colorless, poisonous liquid used as an industrial solvent."People who are exposed to trichloroethylene, such as dry cleaners, are at an increased risk of developing sclerodermalike disease., There are several other triggers of sclerodermalike disease.For example, patients who receive the chemotherapy drug bleomycin can develop lung fibrosis similar to that seen in scleroderma patients," says Feghali-Bostwick.

  • View Online Source
    www.womenshealthresearch.org/site/News2?JServSessionIdr - [Cached Version]
    Published on: 6/5/2008    Last Visited: 7/28/2008  

    But it seems that we don't know enough: "We don't have all the answers and that is the reason why we need to do more research," says Carol Feghali-Bostwik, Ph.D., assistant professor of medicine at the University of Pittsburgh.
    ...
    "We don't quite know why it's more frequent in women but believe that hormonal influences may be responsible for the female preponderance," Feghali-Bostwik said."There is evidence from animal studies that estrogens play a role in the development of fibrosis."

    Having a family member with scleroderma seems to increase a person's risk for developing the disease, but other factors may be at play."Familial studies suggest that there is an increased risk in first degree relatives of scleroderma patients," Feghali-Bostwik said, but "our studies looking at concordance of scleroderma in twins suggest than an inherited genetic background is not sufficient to develop scleroderma."

    Some studies indicate that environmental factors may be involved in causing the disease."Scleroderma is likely a multigenic disease with environmental components serving as triggers.These environmental factors possibly trigger scleroderma in individuals with a susceptible genetic background," explains Feghali-Bostwik.

  • View Online Source
    www.scleroderma.org/e-letters/eLetter_223.htm - [Cached Version]
    Published on: 4/4/2006    Last Visited: 1/6/2008  

    From left: Roger Brechner, SF Chapter and Support Group Manager, Carol Feghali-Bostwick, SF Board Member, and Frannie Waldron, SF CEO
    ...
    From left: Roger Brechner, SF Chapter and Support Group Manager, Carol Feghali-Bostwick, SF Board Member, and Frannie Waldron, SF CEO
    ...
    The visit kicked off when Foundation CEO Frannie Waldron and Foundation board member and researcher Carol Feghali-Bostwick attended a meeting of National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

  • View Online Source
    www.scleroderma.org/news/news2006/news2006_new-board-me - [Cached Version]
    Published on: 3/2/2007    Last Visited: 3/5/2007  

    Joan Provizer, Robert Kacick and Carol Feghali-Bostwick, Ph.D. Join Scleroderma Foundation Board of Directors
    ...
    Joan Provizer, of Michigan, and Robert Kacick of Chicago along with Carol Feghali-Bostwick, Ph.D., were appointed at the board's December meeting.
    ...
    Carol Feghali-Bostwick, Ph.D.
    ...
    Carol Feghali-Bostwick, Ph.D.
    ...
    Carol Feghali-Bostwick, Ph.D.

  • View Online Source
    www.healthday.com/Article.asp?AID=608444&LNGID=2 - [Cached Version]
    Published on: 9/20/2007    Last Visited: 9/26/2007  

    "No deseamos que la gente piense que hemos encontrado la solución y respuesta finales", apuntó Carol Feghali-Bostwick, profesora asistente de medicina y patología de la Universidad de Pittsburgh, y miembro de la junta de directores de la Scleroderma Foundation.
    ...
    FUENTES: Gisela E. Lindhal, Ph.D., principal research fellow, University College Medical School, London; Carol Feghali-Bostwick, Ph.D., assistant professor, medicine and pathology, University of Pittsburgh; Sept. 20, 2007, New England Journal of Medicine

  • View Online Source
    Biography for Carol Feghali-Bostwick, Ph.D. - [Cached Version]
    Published on: 9/18/2008    Last Visited: 9/18/2008  

    Carol Feghali-Bostwick, Ph.D.
    ...
    Carol Feghali-Bostwick, Ph.D.

  • View Online Source
    Jason Alexander Takes Scleroderma Center Stage - [Cached Version]
    Published on: 6/24/2001    Last Visited: 6/24/2001  

    In looking at 45 pairs of twins , we found that scleroderma was associated with dust and trichloroethylene , a solvent used in dry cleaning , as well as a hormonal influence and a predisposition to develop autoimmune diseases , says Dr. Carol Feghali , research assistant professor of medicine at University of Pittsburgh.

    Out of all the twins we studied , only two pairs , both twins , had scleroderma , says Feghali.One set was identical , the other fraternal , which implies it is not an inherited disease..

    There was a variety of L-tryptophan reported in Japan that caused some scleroderma cases and a cooking oil in Spain that caused several thousand cases.Coal miners in Africa and Germany contracted it due to coal dust..

Page:  1 2 3 4 Next

For Recruiters For Sales Pros

Copyright © 2008 Zoom Information Inc. All rights reserved.

BPS_S5.0.5_newui_RC002_P001.1 OM11